An open label pharmcokinetic study of a topical formulation of lidocaine (SHACT) for pain relief in women receiving an Intra Uterine Device.

Trial Profile

An open label pharmcokinetic study of a topical formulation of lidocaine (SHACT) for pain relief in women receiving an Intra Uterine Device.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Nov 2014

At a glance

  • Drugs Lidocaine (Primary)
  • Indications Procedural pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Aug 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 02 May 2012 New trial record
    • 30 Apr 2012 First patient dosed, as reported by Pharmanest
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top